We are live on ! Find out more
OFIX icon

Orthofix Medical

171 hedge funds and large institutions have $953M invested in Orthofix Medical in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 69 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more call options, than puts

Call options by funds: $5.41M | Put options by funds: $2.22M

67% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 15

6% more funds holding

Funds holding: 162171 (+9)

0.36% less ownership

Funds ownership: 96.34%95.98% (-0.36%)

9% less capital invested

Capital invested by funds: $1.05B → $953M (-$99.9M)

17% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 69

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
171
Holders Change
+9
Holders Change %
+5.56%
% of All Funds
3.81%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
25
Increased
57
Reduced
69
Closed
15
Calls
$5.41M
Puts
$2.22M
Net Calls
+$3.19M
Net Calls Change
+$3.35M
Name Holding Trade Value Shares
Change
Change in
Stake
HI
126
HBK Investments
Texas
$335K -$476K -8,367 -57%
SOADOR
127
State of Alaska Department of Revenue
Alaska
$331K +$5.12K +90 +1%
MLICM
128
Metropolitan Life Insurance Company (MetLife)
New York
$323K
MSA
129
Mason Street Advisors
Wisconsin
$308K +$15.5K +273 +5%
PI
130
PineBridge Investments
New York
$301K +$326K +5,737 New
CI
131
Cigna Investments
Connecticut
$296K +$321K +5,650 New
MERSOM
132
Municipal Employees' Retirement System of Michigan
Michigan
$287K +$311K +5,470 New
FQ
133
First Quadrant
California
$271K +$174K +3,058 +145%
WCM
134
Weld Capital Management
New York
$243K +$263K +4,628 New
PIA
135
Piedmont Investment Advisors
North Carolina
$235K +$8.42K +148 +3%
HIMCH
136
Hartford Investment Management Co (HIMCO)
Connecticut
$233K
O
137
OppenheimerFunds
New York
$223K -$97K -1,705 -29%
Nisa Investment Advisors
138
Nisa Investment Advisors
Missouri
$220K
CIM
139
Contravisory Investment Management
Massachusetts
$148K +$9.33K +164 +6%
PAM
140
Panagora Asset Management
Massachusetts
$137K -$81K -1,424 -35%
BNP Paribas Financial Markets
141
BNP Paribas Financial Markets
France
$84.1K -$2.5K -44 -3%
AIP
142
Ameritas Investment Partners
Nebraska
$76K
IUHSA
143
Itau Unibanco Holding S.A.
Brazil
$66K -$106K -1,858 -59%
MWA
144
Marshall Wace Asia
Hong Kong
$58K +$62.9K +1,105 New
Zurich Cantonal Bank
145
Zurich Cantonal Bank
Switzerland
$51K
PCM
146
Prelude Capital Management
New York
$48K +$44.1K +775 +587%
FGC
147
Financial Gravity Companies
Texas
$43K +$45.6K +802 New
ED
148
Exane Derivatives
France
$37.9K +$41.1K +723 New
NIT
149
NumerixS Investment Technologies
British Columbia, Canada
$37K -$62.6K -1,100 -61%
LIA
150
LS Investment Advisors
Michigan
$33K -$42K -738 -54%

OFIX Hedge Fund Activity: Q4 2018 in Review

171 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q4 2018, worth a combined $953M — down 9.5% from $1.05B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new OFIX positions and 15 closed out — a net gain of 10 holders — while 57 added to existing stakes and 69 trimmed.

The largest buyer was Hood River Capital Management, adding an estimated $18.1M. The largest seller was Wellington Management Group, cutting an estimated $14.5M.

  • 171 institutional investors held Orthofix Medical (OFIX) as of Q4 2018, up from 162 in Q3 2018.
  • Funds reported $953M of Orthofix Medical stock for Q4 2018, down 9.5% quarter-over-quarter.
  • 25 funds opened new Orthofix Medical positions in Q4 2018 and 15 closed out, a net change of +10 holders.
  • The largest Orthofix Medical buyer in Q4 2018 was Hood River Capital Management, an estimated $18.1M added.
  • The largest Orthofix Medical seller in Q4 2018 was Wellington Management Group, an estimated $14.5M sold.

Based on aggregated 13F filings for Q4 2018.